Register entryShortage reported

BTG International Inc

Registered sites
1
Drug products
9
Live patents
3
Countries
1
Base
United Kingdom
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Protherics UK LimitedLlandysulUnited KingdomAnalytical testing, Active ingredient (API) manufacture3001417487
Alert

Products in shortage

1
DrugPresentationAvailability
Hydroxocobalamin InjectionCyanokit, Injection, 5 g/250mL (NDC 50633-310-11)Limited Availability
Exclusivity

Patents

3

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
AURLUMYNILOPROSTAug 2041
AURLUMYNILOPROSTJul 2044
VISTOGARDURIDINE TRIACETATEAug 2027
Catalogue

Marketed products

9

Showing 9 of 9.

BrandGeneric nameFormCategory
AURLUMYNILOPROSTINJECTION, SOLUTIONNDA
CroFabovine crotalidae venoms immune fabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
CyanokitHydroxocobalaminINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
DigiFabovine digoxin immune fabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
ThyroSafePotassium IodideTABLETANDA
ThyrosafePotassium iodideTABLETANDA
VISTOGARDuridine triacetateGRANULENDA
VoraxazeglucarpidaseINJECTION, POWDER, FOR SOLUTIONBLA
XURIDENuridine triacetateGRANULENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.